The company is so far trading up from yesterday’s close of $143.8. Shares last traded at $155.93 just above $141.51, the stock’s 50 day moving average and marginally over the 200 day moving average of $122.62. The 50 day moving average moved up $14.42 and the 200 day average went up by +27.16%.
Short traders are more bullish on shares of the company of late at least if you consider the downtick in short interest. The company realized a fall in short interest between June 15, 2017 and May 31, 2017 of -0.08%. Short interest decreased from 8,146,731 to 8,139,861 over that timeframe. With short interest at 8,139,861 and short average daily volume at 442,692, the short-interest ratio is 18.4 and the percentage of shorted shares was 0.20% on May 31.
Here is the rundown on market activity for athenahealth, Inc. (NASDAQ:ATHN). Jonathan D. Porter, SVP, Network Services disclosed the sale of 422 shares of (ATHN). The shares were purchased at an average price of $154.00. Porter now owns $2,815,274 of the stock according to the SEC filing. Jonathan D. Porter, SVP, Network Services sold $42,939 worth of shares at an average price of $143.13 on Mon the 17th. That brings Porter’s holdings to $2,676,960 per an SEC filing yesterday.
Sr VP Karl Stubelis sold 3,952 shares at a price of $139.00 on Mon the 5th. That brings the Sr VP’s holdings to $2,482,262 as recorded in a recent Form 4 SEC filing.
athenahealth, Inc., launched on August 21, 1997, provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet. The Company has a range of network-enabled services to support healthcare providers across the continuum of care. The Company offers various combinations of its services to its clients, including athenaOne and athenaOne for Hospitals and Health Systems, depending on whether they are medical groups and practices or hospitals and larger health systems. As of December 31, 2016, the Company connected care across a national network of approximately 88,000 providers and approximately 86 million patients. The Business’s suite of network-enabled services includes athenaCollector, athenaClinicals, athenaCommunicator, athenaCoordinator, Population Health and Epocrates..
These funds have also shifted positions in (ATHN). Huntington National Bank added to its stake by buying 4,010 shares an increase of 7.9%. Huntington National Bank owns 55,010 shares valued at $7,732,000. The value of the position overall is up by 34.5%. Wealthtrust-arizona, LLC bolstered its investment by buying 10 shares an increase of 6.7% as of 06/30/2017. Wealthtrust-arizona, LLC controls 160 shares with a value of $22,000. The total value of its holdings increased 29.4%.
As of quarter end Gagnon Securities LLC had disposed of a total of 35,262 shares trimming its stake by 36.2%. The value of the investment in ATHN decreased from $10,982,000 to $8,741,000 a change of 20.4% quarter over quarter. Gagnon Advisors, LLC divested its position by shedding 13,371 shares a decrease of 32.8% in the quarter. Gagnon Advisors, LLC currently owns 27,370 shares worth $3,847,000. The total value of its holdings decreased 16.2%.
On July 7, 2017 Argus started covering the stock with an initial rating of “Hold”. On June 13 the company was rated “Neutral” by Cantor Fitzgerald which is down from the previous “” rating.
On May 19 the company was upgraded from “Hold” to “Hold” in a statement from Jefferies. Equity analyst Dougherty began coverage of ATHN giving it an initial rating of “Buy”.
November 23 investment analysts at Barclays kept the company rating at “Underweight” and lowered the price expectation from $110.00 to $97.00. On October 28, 2016 the stock rating was set at “Neutral” in a report from JP Morgan which was a cut from the previous “Overweight” rating.
The company’s P/E ratio is 306.95 and the market value is 6.21B. As of the latest earnings report the EPS was $0.51 and is estimated to be $1.86 for the current year with 39,834,000 shares now outstanding. Next quarter’s EPS is forecasted to be $0.62 and the next full year EPS is projected to be $2.38.